Squarepoint’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
Other funds holding SPPI
AC
ACM
Squarepoint's SPPI Position: Q1 2022 in Review
Squarepoint sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2022, closing a stake of 85,504 shares — an estimated $109K sold.
Squarepoint first reported a position in SPPI in Q4 2015 and held it in 18 quarters. The position peaked at $2.42M in Q3 2018. 101 funds tracked by Wall St. Rank hold SPPI as of Q1 2022.
- Squarepoint reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Squarepoint sold 85,504 Spectrum Pharmaceuticals Inc shares in Q1 2022, an estimated $109K.
- Squarepoint first reported a position in Spectrum Pharmaceuticals Inc in Q4 2015 and held it in 18 quarters.
- Squarepoint's Spectrum Pharmaceuticals Inc position peaked at $2.42M in Q3 2018.
- 101 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2022.
Based on Squarepoint's 13F filing for Q1 2022, filed 16 May 2022.